Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Mar 26, 2026
4 Mar 20, 2026 4
4 Mar 19, 2026 4
8-K Mar 17, 2026 8-K
S-8 Feb 27, 2026 S-8
10-K Feb 27, 2026 10-K
SCHEDULE 13G/A Feb 17, 2026
8-K Dec 31, 2025 8-K
8-K Dec 16, 2025 8-K
SCHEDULE 13G/A Nov 14, 2025
8-K Nov 13, 2025 8-K
10-Q Nov 5, 2025 10-Q
8-K Oct 28, 2025 8-K
8-K Aug 19, 2025 8-K
4 Aug 15, 2025 4
SCHEDULE 13G/A Aug 14, 2025
4 Aug 13, 2025 4
144 Aug 12, 2025
10-Q Aug 7, 2025 10-Q
8-K Jul 17, 2025 CURRENT REPORT
8-K Jun 26, 2025 CURRENT REPORT
8-K Jun 17, 2025 FORM 8-K
4 Jun 12, 2025 4
4 Jun 12, 2025 4
4 Jun 12, 2025 4
← Newer Page 2 of 26 · 646 filings Older →